- Home
- MAS
as 07-04-2025 11:36am EST
Masco manufactures a variety of home improvement and building products. The company's $5-billion plumbing segment, led by the Delta and Hansgrohe brands, sells faucets, showerheads, and other related plumbing fixtures and components. The $3-billion decorative architectural segment primarily sells paints and other coatings under the Behr and Kilz brands, but it also sells builder hardware and lighting products.
| Founded: | 1929 | Country: | United States |
| Employees: | N/A | City: | LIVONIA |
| Market Cap: | 12.9B | IPO Year: | N/A |
| Target Price: | $72.65 | AVG Volume (30 days): | 2.3M |
| Analyst Decision: | Buy | Number of Analysts: | 13 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 3.66 | EPS Growth: | -10.53 |
| 52 Week Low/High: | $56.55 - $86.70 | Next Earning Date: | 07-31-2025 |
| Revenue: | $7,703,000,000 | Revenue Growth: | -2.67% |
| Revenue Growth (this year): | -1.92% | Revenue Growth (next year): | 4.05% |
Latest Masco Corporation News
MAS Breaking Stock News: Dive into MAS Ticker-Specific Updates for Smart Investing
Morningstar Research
8 days ago
Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover
StockStory
12 days ago
Q1 Rundown: Masco (NYSE:MAS) Vs Other Home Construction Materials Stocks
Barchart
12 days ago
Is Masco Stock Underperforming the Dow?
StockStory
15 days ago
Masco’s Q1 Earnings Call: Our Top 5 Analyst Questions
StockStory
23 days ago
Q1 Earnings Highs And Lows: Quanex (NYSE:NX) Vs The Rest Of The Home Construction Materials Stocks
StockStory
24 days ago
3 Profitable Stocks with Mounting Challenges
StockStory
24 days ago
Unpacking Q1 Earnings: Trex (NYSE:TREX) In The Context Of Other Home Construction Materials Stocks
PR Newswire
a month ago
Behr Unveils Second Annual Commercial Color Forecast and New Designer Council
Compare MAS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MAS Masco Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.